Cargando…
P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429569/ http://dx.doi.org/10.1097/01.HS9.0000969176.88981.2a |
_version_ | 1785090747514486784 |
---|---|
author | Tan, Tran-Der Chiou, Lun-Wei |
author_facet | Tan, Tran-Der Chiou, Lun-Wei |
author_sort | Tan, Tran-Der |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429569 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104295692023-08-17 P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS Tan, Tran-Der Chiou, Lun-Wei Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429569/ http://dx.doi.org/10.1097/01.HS9.0000969176.88981.2a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Tan, Tran-Der Chiou, Lun-Wei P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS |
title | P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS |
title_full | P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS |
title_fullStr | P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS |
title_full_unstemmed | P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS |
title_short | P568: COMPARISON OF VENETOCLAX-BASED INDUCTION THERAPY OR 3 + 7 FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED AML PATIENTS |
title_sort | p568: comparison of venetoclax-based induction therapy or 3 + 7 followed by allogeneic hematopoietic stem cell transplantation for newly diagnosed aml patients |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429569/ http://dx.doi.org/10.1097/01.HS9.0000969176.88981.2a |
work_keys_str_mv | AT tantrander p568comparisonofvenetoclaxbasedinductiontherapyor37followedbyallogeneichematopoieticstemcelltransplantationfornewlydiagnosedamlpatients AT chioulunwei p568comparisonofvenetoclaxbasedinductiontherapyor37followedbyallogeneichematopoieticstemcelltransplantationfornewlydiagnosedamlpatients |